HighFlowMusc: Physiological Effects of HFNC During Exercise in Patients With Fibrosing Interstitial Lung Diseases

Sponsor
ADIR Association (Other)
Overall Status
Recruiting
CT.gov ID
NCT05372926
Collaborator
(none)
16
1
2
21
0.8

Study Details

Study Description

Brief Summary

in this study, the investigators aim to describe the effects of highflow nasal canulae oxygen therapy (HFNC) on respiratory muscle function during exercise in patients with fibrosing interstitial lung diseases (ILD) during an endurance test

Condition or Disease Intervention/Treatment Phase
  • Device: high flow nasal canulae
  • Device: Ventury mask
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
16 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
All patients were randomly allocated into two groups using the block randomization technique (blocks of eight patients) in a 1:1 ratio. In group A, a high-intensity constant work-rate endurance test using Venturi mask (VM) was performed on first, and a test using high-flow nasal canulae oxygen therapy (HFNC) was performed next. In group B, a high-intensity CWRET using HFNC was performed first, and a test using VM was performed next.All patients were randomly allocated into two groups using the block randomization technique (blocks of eight patients) in a 1:1 ratio. In group A, a high-intensity constant work-rate endurance test using Venturi mask (VM) was performed on first, and a test using high-flow nasal canulae oxygen therapy (HFNC) was performed next. In group B, a high-intensity CWRET using HFNC was performed first, and a test using VM was performed next.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of the Physiological Effects of High Flow Nasal Canulae Oxygen Therapy During Exercise in Patients With Fibrosing Interstitial Lung Diseases
Anticipated Study Start Date :
Jul 10, 2022
Anticipated Primary Completion Date :
Apr 10, 2024
Anticipated Study Completion Date :
Apr 10, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Venturi mask

Patients will be placed under oxygen therapy with Venturi mask at a constant flow of 15L/min and a set FiO2 of 50%. The real FiO2 will be mesured in the mask at rest.

Device: Ventury mask
Ventury mask is a oxygen therapy technic which allows the administration with a mask of oxygen with a flow up to 15L/Min and a monitored FiO2.

Experimental: High flow nasal canulae

Patients will be placed under high flow nasal canulae oxygen therapy with a constant flow of 50L/min and the real FiO2 provided by Venturi mask.

Device: high flow nasal canulae
high flow nasal canulae is a oxygen therapy technic which allows the administration of warmed and humidified oxygen with a flow up to 50L/Min and a monitored FiO2. Physiological previous studies reported various effects of this technic especially on work of breathing. In our study the investigators aim to test this physiological property during exercise.

Outcome Measures

Primary Outcome Measures

  1. Ptdi swing [during the intervention, at isotime]

    To compare the change in transdiaphragmatic pressure between baseline and peak during inspiration (Ptdi swing) between HFNC and VM in patients with fibrosing Interstitial Lung Disease in stable state, at isotime.

Secondary Outcome Measures

  1. PTPdi [during the intervention, at isotime]

    on effort at isotime, comparison between HFNC and VM of diaphragmatic pressure time product during a respiratory cycle (PTPdi)

  2. PTPoeso [during the intervention, at isotime]

    on effort at isotime, comparison between HFNC and VM of the respiratory "Pressure Time Product" during a respiratory cycle (PTPoeso)

  3. Poeso swing [during the intervention, at isotime]

    on effort at isotime, comparison between HFNC and VM of variation of oesophagal pressure between the base state and the peak (Poeso swing)

  4. DeltaPtdi/DeltaEAdi [during the intervention, at isotime]

    on effort at isotime, comparison between HFNC and VM of the electromechanical coupling of the diaphragm (ratio of variation of the transdiaphragmatic pressure by the variation of electrical activity of the diaphragm (EAdi) between the start of inspiration and the end of expiration, (DeltaPtdi/DeltaEAdi)

  5. SmO2 [during the intervention, at isotime]

    on effort at isotime, comparison between HFNC and VM of the measurement of tissue saturation in oxygen (SmO2) by "Near Infrared Spectrometry" (NIRS)

  6. TcCO2 [during the intervention, at isotime]

    on effort at isotime, comparison between HFNC and VM of transcutaneous CO2 measurement (TcCO2)

  7. Tlim [during the intervention, at the end of endurance test]

    Comparison of endurance time (Tlim) between HFNC and VM

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Cared for as part of a respiratory rehabilitation program (ADIR association)

  • Presenting diffuse fibrosing interstitial pneumonitis, documented by CT scan data and whatever its etiology

  • Presenting severe hypoxemia in ambient air (SpO2<90%) during an exercise test (6-minute walk test or functional exercise test)

Exclusion Criteria:
  • Patient with a contraindication to carrying out a respiratory rehabilitation program

  • Patient having presented an exacerbation of PID, pneumothorax or pneumomediastinum in the 3 months preceding potential inclusion

  • Tracheostomized patient

  • Patient with a contraindication to the placement of a nasogastric tube

  • Pregnant or breastfeeding women or women of childbearing age without effective means of contraception (a pregnancy test will be carried out)

  • Protected adult patient (guardianship or curatorship)

  • Patient deprived of liberty by court or administrative decision

  • Refusal of patient participation or consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 ADIR association Bois-Guillaume France 76230

Sponsors and Collaborators

  • ADIR Association

Investigators

  • Principal Investigator: Elise ARTAUD-MACARI, MD, ADIR Association

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
ADIR Association
ClinicalTrials.gov Identifier:
NCT05372926
Other Study ID Numbers:
  • HighFlowMusc
First Posted:
May 13, 2022
Last Update Posted:
Jul 11, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by ADIR Association
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 11, 2022